AusBiotech has commissioned research into what Australia requires to manufacture more cell and gene products.
There is an opportunity for Australia to be a regional hub in the Asia Pacific region for cell and gene manufacturing, yet several barriers exist. These include quality control processes, infrastructure and large gaps in the people-based capability for manufacturing. Unlocking Australia’s opportunities requires a much better understanding and coordination of our capabilities and addressing where the gaps lie.
The project is funded by the Victorian Government’s Australian Medtech Manufacturing Centre (AMMC) and is being developed by strategic planning and commercialisation firm for the biopharmaceutical and medical device sector, Biointelect. It will outline a strategy and specific recommendations to help the industry unlock opportunities in cell and gene manufacturing.
It will also include updated data from Australia’s Regenerative Medicine Manufacturing Capacity & Capability report, which was previously published in 2021.
AusBiotech has launched an online survey seeking comments on a series of objectives developed as the core of this national strategy. It is estimated that this survey will take no more than 15 minutes to complete and will be emailed to AusBiotech members. Others wishing to contribute to the report are invited to contact Karen Parr, Director of Communications and Policy.